AstraZeneca’s coronavirus vaccine could still be available by the end of the year, or early next year, according to the company’s chief executive, Pascal Soriot, despite clinical trials being paused after a volunteer fell ill.AstraZeneca and Oxford University, which are jointly developing the vaccine and testing it on 50,000 to 60,000 people around the world, halted trials on Wednesday to investigate the “potentially unexpected illness” of one participant.Soriot was unable to say when the trial would resume, but said “I still think we are on track for having a set of data that we would submit before the end of the year” for regulatory approval.Soriot said he was confident that combined with the vaccines being developed by other pharmaceutical firms, there would be enough vaccines for the entire world population.
Read more at: https://www.theguardian.com/business/2020/sep/10/oxford-covid-19-vaccine-is-still-possible-this-year-says-astrazeneca-chief
